ARS Pharmaceuticals, Inc. (SPRY)
10.45
+0.52
(+5.24%)
USD |
NASDAQ |
Dec 10, 16:00
10.45
0.00 (0.00%)
After-Hours: 18:24
ARS Pharmaceuticals EPS Diluted (Quarterly): -0.5177 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Lipocine, Inc. | -0.5887 |
| KalVista Pharmaceuticals, Inc. | -0.9183 |
| Vivos Therapeutics, Inc. | -0.4925 |
| MBX Biosciences, Inc. | -0.6321 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -51.15M |
| Revenue (Quarterly) | 32.50M |
| Total Expenses (Quarterly) | 83.65M |
| Enterprise Value | 791.12M |
| Gross Profit Margin (Quarterly) | 74.80% |
| Profit Margin (Quarterly) | -157.4% |
| Earnings Yield | -7.75% |
| Normalized Earnings Yield | -7.754 |